Select a medication above to begin.
Atmeksi
methocarbamol
Adult Dosing .
Dosage forms: SUSP: 750 mg per 5 mL
New FDA Approval: July 2025
- [content coming soon]
musculoskeletal pain, acute
- [content coming soon]
- Info: exact mechanism of action unknown; depresses CNS activity (centrally-acting muscle relaxant)
Peds Dosing .
- Dosage forms: SUSP: 750 mg per 5 mL
New FDA Approval: July 2025
- [content coming soon]
musculoskeletal pain, acute
- [content coming soon]
- Info: exact mechanism of action unknown; depresses CNS activity (centrally-acting muscle relaxant)